Sfoglia per AUTORE
KIM SY
Collezione AOU San Luigi di Orbassano
Items : 2
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1?50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. in Journal for immunotherapy of cancer / J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674.
2025
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23(10):2649-2655. doi: 10.1093/annonc/mds100. Epub 2012 Apr 29.
2012
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Salah S; Watanabe K; Welter S; Park JS; Park JW; Zabaleta J; Ardissone F; Kim J; Riquet M; Nojiri K; Gisabella M; Kim SY; Tanaka K; Al-Haj Ali B;